Preventative tech launched in the US by Scottish firm
Edinburgh-based Calcivis is launching its bioluminescent dental imaging system in the United States.
The company filed a pre-market supplement with the US Food and Drug Administration last year for enhancements to its imaging system and its wireless, handheld imaging device is now approved for commercialisation.
As part of the business’ projected growth in the American market, the company has established its US headquarters in Milton, Massachusetts, and added personnel to its commercial team.
…we are confident that the Calcivis Imaging System will significantly improve patient care and enable restorative dentistry to move to a more preventative approach.
Adam Christie, CEO, Calcivis
Adam Christie, chief executive, said: “With our US commercial team in place and a very user-friendly, ready for market device, we are confident that the Calcivis Imaging System will significantly improve patient care and enable restorative dentistry to move to a more preventative approach.”
The company says that its imaging system will “revolutionise” caries management through early detection, which allows for a more preventative treatment model. The ability to visualise active demineralisation “live” on patients’ teeth will “provide crucial insight as to whether a caries lesion is likely to progress and requires treatment.”
The imaging system applies a patented photoprotein which, in the presence of free calcium ions released from an actively decaying tooth surface, produces a very short, low-level light flash. An integrated intra-oral sensor within the imaging device detects the luminescence and presents clinicians with a chairside demineralisation map.
Comments are closed here.